Autogenomics, Incorporated

Click Here To EMAIL INQUIRY
Contact: Raymond Earl - VP Sales
Web: http://www.autogenomics.com
E-Mail:
Address: 2251 Rutherford Road, Carlsbad, California 92008, USA
Phone: +1-(760)-804-7378 | Fax: +1-(760)-804-7382 | Map/Directions >>

Profile: Autogenomics, Incorporated develops microarray based multiplexing molecular diagnostic platforms, that can be used to assess disease signatures with genomic and proteomic markers in the area of genetic disorders, infectious diseases, cancer & pharmacogenetics. Our product line includes Infiniti® system and in vitro diagnostic assays. Our Infiniti® analyzer is a multiplexing microarray platform used for the detection and analysis of DNA. Our Infiniti™ in vitro diagnostic assay is used as an aid for the diagnosis and evaluation of patients with suspected thrombophilia.

The company was founded in 1999.

FDA Registration Number: 3005406097

12 Products/Services (Click for related suppliers)

• Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System (FDA Code: ODW / 862.3360)

A drug metabolizing enzyme genotyping system is a device intended for use in testing deoxyribonucleic acid (DNA) extracted from clinical samples to identify the presence or absence of human genotypic markers encoding a drug metabolizing enzyme. This device is used as an aid in determining treatment choice and individualizing treatment dose for therapeutics that are metabolized primarily by the specific enzyme about which the system provides genotypic information.

• Diagnostic Aids

• Diagnostic Rapid Test Kits

• Diagnostic Test Kits

• Genetic Testing Equipment

• Genomic Dna Pcr Factor Ii G20210a Mutations Test (FDA Code: NPR / 864.7280)

Factor V Leiden deoxyribonucleic acid (DNA) mutation detection systems are devices that consist of different reagents and instruments which include polymerase chain reaction (PCR) primers, hybridization matrices, thermal cyclers, imagers, and software packages. The detection of the Factor V Leiden mutation aids in the diagnosis of patients with suspected thrombophilia.

• Genomic Dna Pcr Factor V Leiden Mutations Test (FDA Code: NPQ / 864.7280)

• Instrumentation For Clinical Multiplex Test Systems (FDA Code: NSU / 862.2570)

• Medical Software Solutions

• Molecular Diagnostic Services

• Thrombophilia Panel

• Vitamin K Epoxide Reductase Complex Subunit One (Vkorc1) Genotyping System (FDA Code: ODV / 864.7750)

A prothrombin time test is a device used as a general screening procedure for the detection of possible clotting factor deficiencies in the extrinsic coagulation pathway, which involves the reaction between coagulation factors III and VII, and to monitor patients receiving coumarin therapy (the administration of one of the coumarin anticoagulants in the treatment of venous thrombosis or pulmonary embolism).